{"id":"W2080011730","doi":"10.1097/ppo.0b013e3182758985","title":"Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer","year":2012,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic cancer; Gemcitabine; Erlotinib; Medicine; Oncology; FOLFIRINOX; Cancer; Targeted therapy; Adenocarcinoma; Internal medicine; CA19-9; Cancer research; Epidermal growth factor receptor; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000447473,0.001010856,0.001480678,0.002936621,0.0002992735,0.0008253445,0.0007767702,0.001018517,0.003594497],"category_scores_gemma":[0.0004464475,0.0002665274,0.0006106674,0.002367385,0.000405567,0.001125717,0.000544159,0.002034608,0.002921021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005897057,"about_ca_system_score_gemma":0.0006527866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007571065,"about_ca_topic_score_gemma":0.001547052,"domain_scores_codex":[0.9997919,0.00003281699,0.0000255774,0.00002962625,0.0001001242,0.00001988117],"domain_scores_gemma":[0.9998257,0.00007692481,0.0000320627,0.000006384518,0.00004016098,0.00001880556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007735939,0.0001398083,0.0001273964,0.009761741,0.00008344155,0.0003745255,0.00003897122,0.0003192014,0.00280103,0.001549047,0.02724101,0.9574865],"study_design_scores_gemma":[0.00003459809,0.0001168674,0.0006828575,0.001829866,0.00009005672,0.002754133,0.00002860639,0.00007348029,0.0008122961,0.001197933,0.9923631,0.00001625485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001135487,0.9985152,0.0001141254,0.0001233427,0.0001383808,0.000006398304,0.00001175611,0.000007328574,0.0009698737],"genre_scores_gemma":[0.0005952868,0.997968,0.0002311978,0.0001624751,0.0001474147,0.000009338343,0.00002784279,0.000001503851,0.000856944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003594497,"threshold_uncertainty_score":0.01202476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1746658641995349,"score_gpt":0.4643551876132151,"score_spread":0.2896893234136801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}